Amgen Inc
AMGNBuild a strategy around AMGN
Amgen Inc AI Insights
Informational only. Not investment advice.Snapshot
- Debt/equity of 5.7x with 54.6B total debt vs 9.6B equity - tangible book value is NEGATIVE (-32.2B) due to 41.8B intangibles from Horizon acquisition[Debt to Equity]
- ROE of 82% TTM is optically high but driven by thin equity base (9.6B) - ROIC of 10.6% on 64.2B invested capital is more realistic profitability measure[Return on Equity TTM]
- FCF of 11.5B TTM (32% conversion from revenue) covers 5.1B dividend obligation 2.3x despite 2.8B interest expense[Free Cash Flow TTM]
Watch Triggers
- Total Debt: Falls below 50B within 18 months — Signals successful deleveraging; failure suggests FCF diverted or earnings pressure
- Interest Expense TTM: Exceeds 3B or 9% of revenue — Would compress FCF available for dividends and debt paydown
- Goodwill: Any impairment charge announced — Would signal Horizon deal value destruction and further erode equity cushion
Bull Case
FCF machine generating 11.5B TTM (32% margin) with only 1.6B capex - provides firepower to delever while maintaining 9.39/share dividend
Operating margin of 24% vs industry median near 0% reflects durable pricing power in biologics portfolio with 6.9B R&D pipeline investment
Bear Case
Goodwill of 18.7B (194% of equity) creates impairment risk if Horizon assets underperform - would directly hit already-thin equity base
Negative tangible book (-32.2B) and 5.7x debt/equity leave no margin for error - any earnings miss amplifies balance sheet stress
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage AMGN's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Debt reduction will be primary capital allocation priority over next 3 years, limiting buybacks and M&A
- 54.6B debt load post-Horizon
- 2.8B annual interest expense
- Net debt 4.7x EBITDA
Valuation Context
Caveats
AMGN Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$181.31B | — | ||
$226.59B | — | ||
23 | — | ||
$37.22B | +9.1% | — | |
$14.37 | +31.0% | — | |
28.4% | +6.6% | — | |
21.0% | +3.6% | — | |
$8.6B | -21.2% | — | |
101% | -4.4% | — | |
Beta 5Y (Monthly) | unknown | — |
AMGN Dividend History
2026
$5.04002025
$9.52002024
$9.00002023
$8.52002022
$7.76002021
$7.04002020
$6.40002019
$5.80002018
$5.28002017
$4.60002016
$4.00002015
$3.16002014
$2.44002013
$1.88002012
$1.44002011
$0.5600AMGN Stock Splits
AMGN SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
05/01/26 | 03/31/26 | 10-Q | |
02/13/26 | 12/31/25 | 10-K | |
11/05/25 | 09/30/25 | 10-Q | |
08/06/25 | 06/30/25 | 10-Q | |
05/02/25 | 03/31/25 | 10-Q | |
02/14/25 | 12/31/24 | Unknown | |
10/31/24 | 09/30/24 | 10-Q | |
08/07/24 | 06/30/24 | 10-Q | |
05/03/24 | 03/31/24 | 10-Q | |
02/14/24 | 12/31/23 | 10-K | |
10/31/23 | 09/30/23 | 10-Q | |
08/04/23 | 06/30/23 | 10-Q | |
04/28/23 | 03/31/23 | 10-Q | |
02/09/23 | 12/31/22 | 10-K | |
11/04/22 | 09/30/22 | 10-Q | |
08/05/22 | 06/30/22 | 10-Q | |
04/28/22 | 03/31/22 | 10-Q | |
02/16/22 | 12/31/21 | 10-K | |
11/03/21 | 09/30/21 | 10-Q | |
08/04/21 | 06/30/21 | 10-Q | |
04/28/21 | 03/31/21 | 10-Q | |
02/09/21 | 12/31/20 | 10-K | |
10/29/20 | 09/30/20 | 10-Q | |
07/29/20 | 06/30/20 | 10-Q | |
05/01/20 | 03/31/20 | 10-Q | |
02/12/20 | 12/31/19 | 10-K | |
10/30/19 | 09/30/19 | 10-Q | |
07/31/19 | 06/30/19 | 10-Q | |
05/01/19 | 03/31/19 | 10-Q | |
02/13/19 | 12/31/18 | 10-K | |
10/31/18 | 09/30/18 | 10-Q | |
07/27/18 | 06/30/18 | 10-Q | |
04/25/18 | 03/31/18 | 10-Q | |
02/13/18 | 12/31/17 | 10-K | |
10/26/17 | 09/30/17 | 10-Q | |
07/26/17 | 06/30/17 | 10-Q | |
04/27/17 | 03/31/17 | 10-Q | |
02/14/17 | 12/31/16 | 10-K | |
10/28/16 | 09/30/16 | 10-Q | |
07/29/16 | 06/30/16 | 10-Q | |
05/02/16 | 03/31/16 | 10-Q | |
02/16/16 | 12/31/15 | 10-K | |
11/02/15 | 09/30/15 | 10-Q | |
08/05/15 | 06/30/15 | 10-Q | |
04/27/15 | 03/31/15 | 10-Q | |
02/19/15 | 12/31/14 | 10-K | |
10/29/14 | 09/30/14 | 10-Q | |
08/05/14 | 06/30/14 | 10-Q | |
04/30/14 | 03/31/14 | 10-Q | |
02/24/14 | 12/31/13 | 10-K | |
10/29/13 | 09/30/13 | 10-Q | |
08/06/13 | 06/30/13 | 10-Q | |
05/03/13 | 03/31/13 | 10-Q | |
02/27/13 | 12/31/12 | 10-K | |
11/06/12 | 09/30/12 | 10-Q | |
08/08/12 | 06/30/12 | 10-Q | |
05/08/12 | 03/31/12 | 10-Q | |
02/29/12 | 12/31/11 | 10-K | |
11/04/11 | 09/30/11 | 10-Q | |
08/08/11 | 06/30/11 | 10-Q | |
05/10/11 | 03/31/11 | 10-Q | |
02/25/11 | 12/31/10 | 10-K | |
11/04/11 | 09/30/10 | 10-Q | |
08/09/10 | 06/30/10 | 10-Q | |
05/07/10 | 03/31/10 | 10-Q | |
03/01/10 | 12/31/09 | 10-K | |
11/06/09 | 09/30/09 | 10-Q | |
11/08/10 | 09/30/09 | 10-Q | |
08/10/09 | 06/30/09 | 10-Q | |
05/11/09 | 03/30/09 | 10-Q | |
02/27/09 | 12/31/08 | 5 | |
11/07/08 | 09/30/08 | 10-Q | |
08/08/08 | 06/30/08 | 10-Q | |
05/12/08 | 03/30/08 | Unknown | -- |
02/28/08 | 12/31/07 | 10-K | |
11/09/07 | 09/30/07 | 10-Q | |
08/09/07 | 06/30/07 | 10-Q | |
05/09/07 | 03/30/07 | Unknown | -- |
02/28/07 | 12/31/06 | 10-K | |
11/09/06 | 09/30/06 | 10-Q | |
08/09/06 | 06/30/06 | 10-Q | |
05/10/06 | 03/30/06 | Unknown | -- |
03/10/06 | 12/31/05 | 10-K | |
11/09/05 | 09/30/05 | 10-Q | |
08/08/05 | 06/30/05 | 10-Q | |
05/04/05 | 03/30/05 | Unknown | -- |
03/09/05 | 12/31/04 | 5 | |
11/09/04 | 09/30/04 | 10-Q | |
08/06/04 | 06/30/04 | 10-Q | |
05/03/04 | 03/30/04 | Unknown | -- |
03/11/04 | 12/31/03 | 10-K | |
10/30/03 | 09/30/03 | 10-Q | |
07/30/03 | 06/30/03 | 10-Q | |
05/02/03 | 03/30/03 | Unknown | -- |
03/10/03 | 12/31/02 | 10-K | |
11/05/02 | 09/30/02 | 10-Q | |
08/13/02 | 06/30/02 | 10-Q | |
04/29/02 | 03/30/02 | Unknown | -- |
02/26/02 | 12/31/01 | 10-K | |
10/26/01 | 09/30/01 | 10-Q | |
07/27/01 | 06/30/01 | 10-Q | |
05/14/01 | 03/30/01 | Unknown | -- |
03/07/01 | 12/31/00 | 10-K | |
11/14/00 | 09/30/00 | 10-Q | |
08/01/00 | 06/30/00 | 10-Q | |
04/27/00 | 03/30/00 | Unknown | -- |